In an enlightening discussion on lung transplantation, experts emphasized the urgent need to increase lung donations and establish a national registry to enhance medical treatment for transplant patients. They underscored the importance of collaboration between institutions and government support to create an ecosystem that fosters innovation and enables high-risk surgeries at scale.
The panel, titled “Breathing New Life,” brought together renowned lung transplant surgeons and pulmonologists from the United States, Abu Dhabi, and India. The esteemed panelists, including Dr. Atul C Mehta from Cleveland Clinic and Dr. Sandeep Attawar from KIMS, shared their insights and experiences in this groundbreaking field. The panel was organized by The Times of India in collaboration with IMAS Healthcare and the Cleveland Clinic.
Patient evaluation before transplantation is crucial. According to global guidelines, only those patients with pulmonary fibrosis who meet the selection criteria and have no significant contraindications are considered for transplantation. The assessment process, which lasts 4-6 weeks, includes various tests and screenings to ensure a comprehensive evaluation.
COVID-19 has shed light on the importance of lung health and increased awareness about lung diseases. Patient education plays a vital role in addressing medical and non-medical challenges, including long-term financial solvency and the support of caregivers during the transplant journey.
While lung transplantation is still relatively new in India, efforts from NGOs, the government, and opinion leaders are essential to promote organ donation and improve public awareness. The existing National Organ and Tissue Transplant Organization (NOTTO) faces logistical challenges, leading to some patients seeking treatment abroad.
Preventative measures remain the best recourse for lung diseases. Advancements in treatments for conditions like pulmonary hypertension and cystic fibrosis have reduced the need for lung transplantation. Eliminating smoking contributes to a decrease in emphysema cases requiring transplantation. Innovative techniques, such as ex vivo lung perfusion and accepting organs from individuals with past hepatitis, are expanding options for patients.
Moreover, technological advancements such as digital breathing machines and virtual consultations are enhancing post-transplant care. Patients can now access digital breathing machines from home, allowing healthcare professionals to monitor their lung function remotely.
The panel also recognized the significance of holistic well-being in improving lung health. They highlighted the positive effects of practices like yoga and pranayama on lung function, emphasizing the importance of incorporating basic techniques alongside technological advancements.
Overall, the panel’s diverse expertise and collaborative efforts contributed to a comprehensive dialogue on improving lung health, not just in India but globally. The advancements discussed in this discourse have the potential to pave the way for a brighter future in lung transplantation and healthcare.
